Cargando…

Aseptic necrosis at multiple localisations in a lupus patient with lymphoma

Avascular or aseptic necrosis is a well-defined entity leading to the degradation of cellular elements of the bone. The pathogenesis of osteonecrosis (ON) is still unknown. There are two main types of ON: traumatic or non-traumatic. Several clinical entities could associate with ON, systemic disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazso, A., Bazso, T., Szodoray, P., Poor, G., Kiss, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955128/
https://www.ncbi.nlm.nih.gov/pubmed/24297095
http://dx.doi.org/10.1007/s00198-013-2589-x
_version_ 1782307536846716928
author Bazso, A.
Bazso, T.
Szodoray, P.
Poor, G.
Kiss, E.
author_facet Bazso, A.
Bazso, T.
Szodoray, P.
Poor, G.
Kiss, E.
author_sort Bazso, A.
collection PubMed
description Avascular or aseptic necrosis is a well-defined entity leading to the degradation of cellular elements of the bone. The pathogenesis of osteonecrosis (ON) is still unknown. There are two main types of ON: traumatic or non-traumatic. Several clinical entities could associate with ON, systemic diseases, environmental factors, pregnancy, systemic autoimmune or rheumatic diseases, thrombophilia, corticosteroid therapy, cytotoxic dugs, infections, metabolic and hematologic diseases, etc. Corticosteroids (CS) are still the most frequently used therapeutic options in the early phase and during flares of these diseases. Inflammatory cytokines and antibodies have been described to participate in the pathogenesis of ON. The infiltrative disorders of the bone marrow could also contribute to the development of ON. Hereby, we describe a female patient with NHL followed by SLE in whom ON has developed at least in two localisations. Lupus flare, long-term CS therapy, lymphoma relapse or the presence of antiphospholipid antibodies were excluded. Although the bi-localised ON could be contributed to immunologic factors or trauma, the exact aetiology in this case could not be elucidated.
format Online
Article
Text
id pubmed-3955128
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-39551282014-03-24 Aseptic necrosis at multiple localisations in a lupus patient with lymphoma Bazso, A. Bazso, T. Szodoray, P. Poor, G. Kiss, E. Osteoporos Int Case Report Avascular or aseptic necrosis is a well-defined entity leading to the degradation of cellular elements of the bone. The pathogenesis of osteonecrosis (ON) is still unknown. There are two main types of ON: traumatic or non-traumatic. Several clinical entities could associate with ON, systemic diseases, environmental factors, pregnancy, systemic autoimmune or rheumatic diseases, thrombophilia, corticosteroid therapy, cytotoxic dugs, infections, metabolic and hematologic diseases, etc. Corticosteroids (CS) are still the most frequently used therapeutic options in the early phase and during flares of these diseases. Inflammatory cytokines and antibodies have been described to participate in the pathogenesis of ON. The infiltrative disorders of the bone marrow could also contribute to the development of ON. Hereby, we describe a female patient with NHL followed by SLE in whom ON has developed at least in two localisations. Lupus flare, long-term CS therapy, lymphoma relapse or the presence of antiphospholipid antibodies were excluded. Although the bi-localised ON could be contributed to immunologic factors or trauma, the exact aetiology in this case could not be elucidated. Springer London 2013-12-03 2014 /pmc/articles/PMC3955128/ /pubmed/24297095 http://dx.doi.org/10.1007/s00198-013-2589-x Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.5/ Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Case Report
Bazso, A.
Bazso, T.
Szodoray, P.
Poor, G.
Kiss, E.
Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title_full Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title_fullStr Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title_full_unstemmed Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title_short Aseptic necrosis at multiple localisations in a lupus patient with lymphoma
title_sort aseptic necrosis at multiple localisations in a lupus patient with lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955128/
https://www.ncbi.nlm.nih.gov/pubmed/24297095
http://dx.doi.org/10.1007/s00198-013-2589-x
work_keys_str_mv AT bazsoa asepticnecrosisatmultiplelocalisationsinalupuspatientwithlymphoma
AT bazsot asepticnecrosisatmultiplelocalisationsinalupuspatientwithlymphoma
AT szodorayp asepticnecrosisatmultiplelocalisationsinalupuspatientwithlymphoma
AT poorg asepticnecrosisatmultiplelocalisationsinalupuspatientwithlymphoma
AT kisse asepticnecrosisatmultiplelocalisationsinalupuspatientwithlymphoma